REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 17th, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 17th, 2021 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is dated as of June 21, 2021 (the “Effective Date”) by and among AEON Biopharma, Inc., a Delaware corporation (the “Company”), and Medytox, Inc., a company duly organized and existing under the laws of South Korea (the “Investor”), and each other party who hereafter executes and delivers a Joinder Agreement (together with the Investor, the “Holder”) in the form attached as Exhibit A hereto (a “Joinder Agreement”) agreeing to be bound by the terms hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 14th, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 14th, 2021 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is dated as of June 21, 2021 (the “Effective Date”) by and among AEON Biopharma, Inc., a Delaware corporation (the “Company”), and Medytox, Inc., a company duly organized and existing under the laws of South Korea (the “Investor”), and each other party who hereafter executes and delivers a Joinder Agreement (together with the Investor, the “Holder”) in the form attached as Exhibit A hereto (a “Joinder Agreement”) agreeing to be bound by the terms hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 21st, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 21st, 2021 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is dated as of June 21, 2021 (the “Effective Date”) by and among AEON Biopharma, Inc., a Delaware corporation (the “Company”), and Medytox, Inc., a company duly organized and existing under the laws of South Korea (the “Investor”), and each other party who hereafter executes and delivers a Joinder Agreement (together with the Investor, the “Holder”) in the form attached as Exhibit A hereto (a “Joinder Agreement”) agreeing to be bound by the terms hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 12th, 2021 • Evolus, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 12th, 2021 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is dated as of February 18, 2021 (the “Effective Date”) by and among Evolus, Inc., a Delaware corporation (the “Company”), and Medytox, Inc., a company duly organized and existing under the laws of South Korea (the “Investor”), and each other party who hereafter executes and delivers a Joinder Agreement (together with the Investor, the “Holder”) in the form attached as Exhibit A hereto (a “Joinder Agreement”) agreeing to be bound by the terms hereof.